BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22519228)

  • 1. A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico.
    Acevedo P; Jorge JC; Cruz-Sánchez A; Amy E; Barreto-Estrada JL
    West Indian Med J; 2011 Oct; 60(5):531-5. PubMed ID: 22519228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of anabolic androgenic steroids.
    Schänzer W
    Clin Chem; 1996 Jul; 42(7):1001-20. PubMed ID: 8674183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of doping agents, particularly anabolic steroids, in sports and society.
    Sjöqvist F; Garle M; Rane A
    Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic-Androgenic Steroid Use in Sports, Health, and Society.
    Bhasin S; Hatfield DL; Hoffman JR; Kraemer WJ; Labotz M; Phillips SM; Ratamess NA
    Med Sci Sports Exerc; 2021 Aug; 53(8):1778-1794. PubMed ID: 34261998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of testosterone and anabolic androgenic steroids in sport].
    Medraś M; Jóźków P
    Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic steroid use: patterns of use and detection of doping.
    Graham MR; Davies B; Grace FM; Kicman A; Baker JS
    Sports Med; 2008; 38(6):505-25. PubMed ID: 18489196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes.
    Christou GA; Christou MA; Žiberna L; Christou KA
    Eur J Sport Sci; 2019 Oct; 19(9):1276-1286. PubMed ID: 30880613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
    Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
    Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
    Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Athletic Trainers' Association position statement: anabolic-androgenic steroids.
    Kersey RD; Elliot DL; Goldberg L; Kanayama G; Leone JE; Pavlovich M; Pope HG;
    J Athl Train; 2012; 47(5):567-88. PubMed ID: 23068595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
    Huang G; Basaria S
    Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
    Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN
    Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic-androgenic steroid use among young male and female athletes: is the game to blame?
    Harmer PA
    Br J Sports Med; 2010 Jan; 44(1):26-31. PubMed ID: 19919946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.